Literature DB >> 33669686

Maternal Melatonin Deficiency Leads to Endocrine Pathologies in Children in Early Ontogenesis.

Dmitry O Ivanov1, Inna I Evsyukova2, Ekaterina S Mironova3,4, Victoria O Polyakova1, Igor M Kvetnoy4,5, Ruslan A Nasyrov1.   

Abstract

The review summarizes the results of experimental and clinical studies aimed at elucidating the causes and pathophysiological mechanisms of the development of endocrine pathology in children. The modern data on the role of epigenetic influences in the early ontogenesis of unfavorable factors that violate the patterns of the formation of regulatory mechanisms during periods of critical development of fetal organs and systems and contribute to the delayed development of pathological conditions are considered. The mechanisms of the participation of melatonin in the regulation of metabolic processes and the key role of maternal melatonin in the formation of the circadian system of regulation in the fetus and in the protection of the genetic program of its morphofunctional development during pregnancy complications are presented. Melatonin, by controlling DNA methylation and histone modification, prevents changes in gene expression that are directly related to the programming of endocrine pathology in offspring. Deficiency and absence of the circadian rhythm of maternal melatonin underlies violations of the genetic program for the development of hormonal and metabolic regulatory mechanisms of the functional systems of the child, which determines the programming and implementation of endocrine pathology in early ontogenesis, contributing to its development in later life. The significance of this factor in the pathophysiological mechanisms of endocrine disorders determines a new approach to risk assessment and timely prevention of offspring diseases even at the stage of family planning.

Entities:  

Keywords:  children; early ontogenesis; endocrine pathology; family planning; melatonin

Mesh:

Substances:

Year:  2021        PMID: 33669686      PMCID: PMC7922827          DOI: 10.3390/ijms22042058

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  189 in total

Review 1.  Genomic imprinting, growth and maternal-fetal interactions.

Authors:  Féaron C Cassidy; Marika Charalambous
Journal:  J Exp Biol       Date:  2018-03-07       Impact factor: 3.312

Review 2.  Prophylaxis and treatment of foetal growth restriction.

Authors:  Aamod Nawathe; Anna L David
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2018-02-23       Impact factor: 5.237

Review 3.  Fetal programming and gestational diabetes mellitus.

Authors:  Lara J Monteiro; Jane E Norman; Gregory E Rice; Sebastián E Illanes
Journal:  Placenta       Date:  2015-12-12       Impact factor: 3.481

4.  Placental melatonin production and melatonin receptor expression are altered in preeclampsia: new insights into the role of this hormone in pregnancy.

Authors:  Dave Lanoix; Pascale Guérin; Cathy Vaillancourt
Journal:  J Pineal Res       Date:  2012-06-11       Impact factor: 13.007

Review 5.  A rhythmic placenta? Circadian variation, clock genes and placental function.

Authors:  B J Waddell; M D Wharfe; R C Crew; P J Mark
Journal:  Placenta       Date:  2012-04-22       Impact factor: 3.481

Review 6.  Programming of the fetal suprachiasmatic nucleus and subsequent adult rhythmicity.

Authors:  David J Kennaway
Journal:  Trends Endocrinol Metab       Date:  2002-11       Impact factor: 12.015

7.  Function and expression of melatonin receptors on human pancreatic islets.

Authors:  Reshma D Ramracheya; Dany S Muller; Paul E Squires; Helen Brereton; David Sugden; Guo Cai Huang; Stephanie A Amiel; Peter M Jones; Shanta J Persaud
Journal:  J Pineal Res       Date:  2008-01-09       Impact factor: 13.007

8.  The reduction in circulating levels of melatonin may be associated with the development of preeclampsia.

Authors:  K Zeng; Y Gao; J Wan; M Tong; A C Lee; M Zhao; Q Chen
Journal:  J Hum Hypertens       Date:  2016-06-02       Impact factor: 3.012

Review 9.  Melatonin treatment in fetal and neonatal diseases.

Authors:  Fernanda Rodrigues Helmo; Renata Margarida Etchebehere; Natália Bernardes; Maria Flávia Meirelles; Caetano Galvão Petrini; Laura Penna Rocha; Maria Luíza Gonçalves Dos Reis Monteiro; Camila Souza de Oliveira Guimarães; Vicente de Paula Antunes Teixeira; Marlene Antônia Dos Reis; Juliana Reis Machado; Rosana Rosa Miranda Corrêa
Journal:  Pathol Res Pract       Date:  2018-10-23       Impact factor: 3.250

10.  Melatonin Pharmacokinetics Following Oral Administration in Preterm Neonates.

Authors:  Silvia Carloni; Fabrizio Proietti; Marco Rocchi; Mariangela Longini; Lucia Marseglia; Gabriella D'Angelo; Walter Balduini; Eloisa Gitto; Giuseppe Buonocore
Journal:  Molecules       Date:  2017-12-01       Impact factor: 4.411

View more
  4 in total

1.  Exogenous Melatonin Directly and Indirectly Influences Sheep Oocytes.

Authors:  Yang Chen; Xuesong Shan; Huaizhi Jiang; Zhenhua Guo
Journal:  Front Vet Sci       Date:  2022-05-26

Review 2.  Obesity and Maternal-Placental-Fetal Immunology and Health.

Authors:  Meredith Monaco-Brown; David A Lawrence
Journal:  Front Pediatr       Date:  2022-04-28       Impact factor: 3.569

Review 3.  Melatonin as the Cornerstone of Neuroimmunoendocrinology.

Authors:  Igor Kvetnoy; Dmitry Ivanov; Ekaterina Mironova; Inna Evsyukova; Ruslan Nasyrov; Tatiana Kvetnaia; Victoria Polyakova
Journal:  Int J Mol Sci       Date:  2022-02-06       Impact factor: 5.923

Review 4.  Is Melatonin the "Next Vitamin D"?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements.

Authors:  Deanna M Minich; Melanie Henning; Catherine Darley; Mona Fahoum; Corey B Schuler; James Frame
Journal:  Nutrients       Date:  2022-09-22       Impact factor: 6.706

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.